David E Laufer, Age 43Saylorsburg, PA

David Laufer Phones & Addresses

Saylorsburg, PA

1216 52Nd St, Brooklyn, NY 11219 (718) 437-3163 (718) 438-1968 (718) 851-1115

1216 52Nd St #1, Brooklyn, NY 11219 (718) 437-3163

Work

Company: Canaccord genuity corporation 2010 Position: Vice president, institutional trading

Education

School / High School: New York Institute of Finance- New York, NY Apr 2003

Mentions for David E Laufer

Career records & work history

Lawyers & Attorneys

David Laufer Photo 1

David Laufer - Lawyer

Office:
Mayer Brown LLP
ISLN:
1000413324
Admitted:
2016
University:
Fordham University School of Law

David Laufer resumes & CV records

Resumes

David Laufer Photo 41

Experienced Institutional Equity Professional With Extensive Sales And Trading Experience, Seeking New Opportunity

Location:
Greater New York City Area
Industry:
Financial Services
David Laufer Photo 42

David Laufer

David Laufer Photo 43

David Laufer

David Laufer Photo 44

David Laufer

David Laufer Photo 45

David Laufer

David Laufer Photo 46

David Laufer - Stewart Manor, NY

Work:
Canaccord Genuity Corporation 2010 to 2000
Vice President, Institutional Trading
BMO Capital Markets - New York, NY 2001 to 2010
Vice President, Institutional Trading

Publications & IP owners

Us Patents

Substituted Benzenesulfonylureas And -Thioureas--Process For Their Preparation And Their Use As Pharmaceuticals

US Patent:
6090981, Jul 18, 2000
Filed:
May 19, 1998
Appl. No.:
9/081143
Inventors:
Heinrich Englert - Hofheim, DE
Dieter Mania - Konigstein, DE
Jens Hartung - Rodgau, DE
Heinz Gogelein - Frankfurt am Main, DE
Joachim Kaiser - Frankfurt am Main, DE
Wolfgang Linz - Mainz, DE
David W. Laufer - Phillipsburg NJ
Assignee:
Hoechst Aktiengesellschaft - Frankfurt am Main
International Classification:
C07C31116
US Classification:
564 86
Abstract:
Benzenesulfonylureas and -thioureas of the formula I ##STR1## where R(1) is H or (fluoro)methyl, R(2) is H, Hal or (fluoro)(mercapto)alk(ozy)yl, E is O or S; Y is --[CR(3). sub. 2 ]. sub. n --, where R(3)=H or alkyl and n=1-4, X is H, Hal or alkyl and Z in Hal, NO. sub. 2 or alk(yl)oxy, are described. The compounds I are used for treatment of disturbances in cardiac rhythm and prevention of sudden cardiac death caused by arrhythmia, and can therefore be used as antiarrhythmics. They are particularly suitable for those cases where arrhythmias are a consequence of a narrowing of a coronary vessel, such as angina pectoris or acute cardiac infarction.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.